Last updated on December 2018

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin


Brief description of study

The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin

Clinical Study Identifier: NCT03143153

Contact Investigators or Research Sites near you

Start Over

Site 0176

Local Institution
Ota, Japan
2.41miles
  Connect »